Literature DB >> 23233149

A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

Qian Yu1, Li Zhang, Lichen Ouyang, Yeli Gong, Zhihui Liang, Guanxin Shen, Xiufang Weng, Xiongwen Wu.   

Abstract

Raising tumor-specific allorestricted T cells in vitro for adoptive transfusion is expected to circumvent host tumor tolerance. However, it has been assumed that alloreactive T cell clones activated in vitro ranges from peptide-specific with high avidity to peptide-degenerate with low avidity. In this study, we examined the peptide specificity and cross-reactivity of T cell responses in vitro to an allogeneic epitope and a nominal epitope with a modified co-culture of lymphocytes and autologous monocytes. After binding to the monocyte via the interaction of its Fc part and the cell surface IgG Fc receptor type I (FcγRI), a fusion protein consisting of the extracellular domains of HLA-A2 molecule and the Fc region of IgG1 (the dimer) introduced a single epitope into the co-culture. The dimer-coated monocytes stimulated the proliferation of autologous CD8(+) T cells after co-culturing. The CD8(+) T cell responses were self-HLA-restricted for HLA-A2-positive (HLA-A2+ve) samples and allo-HLA-restricted for HLA-A2-negative (HLA-A2-ve) samples, since the co-cultural bulks stained with HLA-A2 tetramers, human interferon-gamma (IFN-γ) production in response to T cell receptor (TCR) ligands, and cytotoxicity against a panel of target cells exhibited peptide-specific properties. Two HLA-A2-restricted peptides with sequence homology were included, allowing the comparison of cross-reactivity between allo-antigen- and nominal antigen-induced CD8(+) T cell responses. Interestingly, the allo- and self-HLA-restricted CD8(+) T cell responses were similar in the peptide cross-reactivity, although the allorestricted T cell response seemed, overall, more intensive and had higher binding affinity to specific tetramer. Our findings indicated the alloreactive T cells raised by the co-culture in vitro were as peptide specific and cross-reactive as the self-HLA-restricted ones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233149     DOI: 10.1007/s00251-012-0668-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  60 in total

1.  Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.

Authors:  T M Hornell; J C Solheim; N B Myers; W E Gillanders; G K Balendiran; T H Hansen; J M Connolly
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  The paradox of alloreactivity and self MHC restriction: quantitative analysis and statistics.

Authors:  V Detours; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 3.  The structural basis of T-cell allorecognition.

Authors:  A Whitelegg; L D Barber
Journal:  Tissue Antigens       Date:  2004-02

4.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

Review 5.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Selection and continuous growth of antigen-specific human T cells by antigen-treated monocytes.

Authors:  V Barak; Z Fuks; N Galilli; A J Treves
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

7.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Authors:  K M Chang; B Rehermann; J G McHutchison; C Pasquinelli; S Southwood; A Sette; F V Chisari
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

9.  Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon.

Authors:  Swati B Gupta; Christopher T Mast; Nathan D Wolfe; Vlad Novitsky; Sheri A Dubey; Esper G Kallas; Mauro Schechter; Bernard Mbewe; Eftyhia Vardas; Punee Pitisuttithum; Donald Burke; Dan Freed; Robin Mogg; Paul M Coplan; Jon H Condra; Romnie S Long; Kiersten Anderson; Danilo R Casimiro; John W Shiver; Walter L Straus
Journal:  J Acquir Immune Defic Syndr       Date:  2006-06       Impact factor: 3.731

10.  CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Authors:  Kam Fai Tse; Michael Jeffers; Vincent A Pollack; Denise A McCabe; Melanie L Shadish; Nikolai V Khramtsov; Craig S Hackett; Suresh G Shenoy; Bing Kuang; Ferenc L Boldog; John R MacDougall; Luca Rastelli; John Herrmann; Michael Gallo; Gadi Gazit-Bornstein; Peter D Senter; Damon L Meyer; Henri S Lichenstein; William J LaRochelle
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

View more
  2 in total

1.  Puerarin alleviates delayed-type hypersensitivity via cytokine inhibition by modulating Th1/Th2 balance.

Authors:  Jing Tong; Xi-Jiang Hu; Wen-Qian Cai; Xiang Dai; Lei Wang
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

2.  Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice.

Authors:  Liping Guan; Xiaoyi Li; Jiali Wei; Zhihui Liang; Jing Yang; Xiufang Weng; Xiongwen Wu
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.